More than 32,000 boxes of a generic medication against hypertension and heart failure, Lisinopril, were recalled in France due to a “lack of printing” on plates “which can induce a risk of overdose”, said the National Agency for Medicines (ANSM) on Tuesday.
“Loving confusion”
The quality of the tablets marketed by the American laboratory Viatris “is not called into question” but “the registration present on the aluminum of the brochure can be confusing because it suggests that it is necessary to take several tablets certain days”, specifies the ANSM in a press release.
In total, four Lisinopril lots dosed at 5 mg are affected (lots 8172295, 8189879, 8172296, 8192737), or 32,640 boxes, according to a count obtained from the ANSM.
-In the event of overdose, it is possible to feel fatigue, balance disorders, hypotension and “alteration of kidney function may occur”, warns the drug’s guardian. A case of overdose accompanied by an unworthy confusing state has been reported, according to the ANSM.
Alternatives available
Until new lots with compliant plates are “soon available”, no supply voltage in Lisinopril is planned following this recall, according to the agency, because “alternatives are available”.
Other genericers, such as Biogaran, Teva, Zentiva, Sandoz or Arrow offer this molecule, according to the Vidal Data Database in France.
